ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Editorial: Rumor Mill Fills The Gap When Access Denied

December 16, 1994

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

September 14, 1979

New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues

January 3, 1975

Nominations Sought For Women’s Health Achievement AwardsFor Medical Devices

February 7, 1997

Support For Translational Researchers Urgently Needed, ASCO President Says

May 22, 1998